巍華新材(603310.SH):擬5000萬元參與認購股權投資基金份額
格隆匯6月24日丨巍華新材(603310.SH)公佈,嘉興長沛昕泉股權投資合夥企業(有限合夥)(簡稱“標的基金”或“合夥企業”),標的基金嘉興長沛昕泉股權投資合夥企業(有限合夥)原合夥人張澤平退出,公司與陳科、方國寶、羅玉芳、王洪利、謝丹、嘉興長沛私募基金管理合夥企業(有限合夥)(簡稱“嘉興長沛”)等合夥人合計認繳出資6,205萬元。公司以自有資金認繳出資5,000萬元,佔總份額的比例為80.5802%。標的基金的普通合夥人、執行事務合夥人及基金管理人為嘉興長沛,標的基金主要投資於未上市企業股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.